By Chris Wack
Avid Bioservices shares were up 12% at $12.25 after getting a buyout offer from GHO Capital Partners and Ampersand Capital Partners.
Under the terms of the buyout, Avid will be acquired by funds managed by GHO and Ampersand in an all-cash transaction valued at $1.1 billion, or $12.50 per share in cash.
The per-share purchase price represents a 13.8% premium to Avid's closing share price of $10.98 on Wednesday, and a 21.9% premium to the company's 20-day volume-weighted average share price for the period ended Wednesday.
Upon completion of the transaction, Avid common stock will no longer be listed on any public stock exchange. The company will continue to operate under the Avid name and brand.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
November 07, 2024 10:29 ET (15:29 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.